Piramal Imaging recently announced that it will present nine studies on the effects of Neuraceq (florbetaben F18 injection) at the Alzheimer’s Association International Annual Conference (AAIC), July 18-23, 2015 at the Walter E. Washington Convention Center in Washington, D.C. Neuraceq is indicated for Positron Emission Tomography (PET) imaging of…
With recent developments in stem cell research opening up the enormous potential for advancing the field of regenerative medicine, researchers are exploring ways that stem cell therapeutics may prove able to treat and possibly even reverse effects of debilitating diseases such as Alzheimer’s, type 1 diabetes and muscular dystrophy. Professionals…
Researchers at Cedars-Sinai Medical Center recently published in the journal Brain a new promising immune therapeutic strategy for Alzheimer’s disease using mice models. The study is entitled “Therapeutic effects of glatiramer acetate and grafted CD115+ monocytes in a mouse model of Alzheimer’s disease”.
Researchers from Columbia University Medical Center (CUMC) have released multiple study findings showing that long term memories are stored with the help of prion-like proteins called CPEB. These CPEB proteins work to form long term memory in the same way as the mechanisms that cause mad cow disease, kuru, and other…
Alzheimer’s disease is responsible for up to 70% of cases of dementia. It is a chronic neurodegenerative disease that usually starts with difficulty remembering recent events. It is often a patient’s family member that notices this loss of function and that urges the patient to see the doctor. Presently, there…
In a new study entitled “Novel DNA repair mechanism brings new horizons: Researchers discover new mechanism of DNA repair, which will help to treat and to prevent diseases in the future” researchers discovered a new mechanism on how the DNA molecule repairs itself which may translate into…
In a recent study published in the journal Computational and Mathematical Methods in Medicine, a team of researchers found that the use of multiscale entropy analysis (MSE), of EEG signals, especially Slope 2, provides a potential tool for predicting the efficacy of AChE inhibitors prior to…
A recent study titled, “ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment,” reported in this month’s issue of The FASEB Journal, is backing all the hype surrounding fish oil and antioxidant supplements as a potential means to…
Axovant Sciences Ltd., a clinical-stage biopharmaceutical company addressing the cognitive, behavioral, and functional components of dementia, recently announced that two presentations on the company’s drug development efforts have been accepted for the 2015 International Conference of the Alzheimer’s Association (AAIC) that will take place in Washington, D.C. from the…
Researchers at Newcastle University in the United Kingdom recently revealed their findings on alterations in the brain network of patients with disorders linked to dementia, namely dementia with Lewy bodies (DLB) and Alzheimer’s disease. The study was published in the journal Neurobiology of Aging and is…
Get regular updates to your inbox.